Affinivax
Fran Heller has over 25 years of experience in the pharmaceutical and biotech industries in business development, licensing, and legal affairs. Currently, Ms. Heller is the Founder, CEO, and Chair of Good2Go, Inc. an IoT technology company. She also co-chairs the LavaMaeˣ board, a nonprofit that promotes well-being to people experiencing homelessness. Previously she was senior vice president of business development at Bristol-Myers Squibb, a Trustee of the Bristol-Myers Squibb Foundation, a Trustee at Dana Farber Cancer Institute, and an adviser to GoFundMe’s Impact Fund. Ms. Heller is a member of the California State Bar and licensed by the U.S. Patent and Trademark Office. She holds a B.S. in biology from Tulane University, an M.A. in biology from American University, and a J.D. from Golden Gate University School of Law.
This person is not in the org chart
This person is not in any offices
Affinivax
1 followers
Affinivax is a clinical stage biotechnology company developing a next generation approach in vaccine technologies to design both preventive and therapeutic vaccines that provide broader protection against infectious and other immune mediated diseases.